Nu-Tek BioSciences
PrivateLast Round
Early Funding
Oct 23, 2025
Total Funding Raised
$500,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nu-Tek BioSciences is a biotechnology company that develops and manufactures animal-free peptones and protein hydrolysates for the pharmaceutical and wellness food industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Pharma Supply Chain
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nu-Tek BioSciences Comparables
Compare Nu-Tek BioSciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Organotechnie SAS | 77% | |
| Global BioIngredients, Inc. | 76% | |
| Neomend | 76% |
Nu-Tek BioSciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 23, 2025 | ||||
| Early Funding | May 1, 2024 | ||||
| Debt | Mar 3, 2021 | ||||
| Grant | Mar 3, 2021 |
Nu-Tek BioSciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agent Capital | Early Funding |
| Minnesota Department of Employment and Economic Development | Debt, Grant |
| 1315 Capital | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 246% MoM, from 319 to 1.1K.
- Mar 3, 2026
Monthly visitors grew 94% MoM, reaching 4.2K.
Recent news
Latest coverage and updates
- attends_eventAug 25, 2026
Nu-Tek BioSciences, LLC will attend event BioProcess International East on Sep 22nd '26.
Nu-Tek BioSciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nu-Tek BioSciences's valuation, stock price, and market status.
Is Nu-Tek BioSciences a public or private company?
Nu-Tek BioSciences is a private company.
What is the current stock price of Nu-Tek BioSciences?
Nu-Tek BioSciences is a private company with no public stock price. No recent secondary market data is available.
How much is Nu-Tek BioSciences worth (valuation)?
Valuation information for Nu-Tek BioSciences is not publicly available.
Can I buy Nu-Tek BioSciences stock?
Nu-Tek BioSciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nu-Tek BioSciences's last funding round?
Nu-Tek BioSciences's most recent funding round was Early Funding on October 23, 2025.
Who are the main investors in Nu-Tek BioSciences?
Key investors in Nu-Tek BioSciences include 1315 Capital.
Will Nu-Tek BioSciences IPO soon?
No public IPO plans have been announced for Nu-Tek BioSciences.
How can I track Nu-Tek BioSciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nu-Tek BioSciences's secondary market activity and sign up for updates.